Finance

Lists
PANACEABIO:NSE
Panacea Biotec Ltd
₹371.60
-0.11%
(-0.40) 1D
Sep 18, 9:33:06 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for PANACEABIO...
Open
₹373.00
High
₹375.80
Low
₹371.60
Mkt. cap
22.76B
Avg. vol.
0.00
Volume
3.45K
52-wk high
₹647.00
52-wk low
₹292.40
EPS
-₹1.16
Shares outstanding
61.25M
No. of employees
1K
Open
₹373.00
High
₹375.80
Low
₹371.60
Mkt. cap
22.76B
Avg. vol.
0.00
Volume
3.45K
52-wk high
₹647.00
52-wk low
₹292.40
EPS
-₹1.16
Shares outstanding
61.25M
No. of employees
1K
Profile
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
About Panacea Biotec Ltd
CEO-
Employees1.15K
Founded1984
Headquarters-
SectorBiotechnology
Websitepanaceabiotec.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.41B
1.65B
1.67B
2.00B
Cost of goods sold
589.40M
679.30M
763.90M
1.02B
Cost of revenue
589.40M
679.30M
763.90M
1.02B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477.10M
405.30M
468.20M
441.60M
Operating expense
1.08B
939.70M
956.70M
1.00B
Total operating expenses
1.67B
1.62B
1.72B
2.02B
Operating income
-261.30M
32.90M
-53.10M
-22.30M
Other non operating income
64.00M
22.80M
25.50M
42.40M
EBT including unusual items
-191.70M
64.90M
-12.50M
35.70M
EBT excluding unusual items
-218.70M
37.20M
-39.60M
8.30M
Income tax expense
-51.60M
26.00M
-2.50M
13.70M
Effective tax rate
26.92%
40.06%
20.00%
38.38%
Other operating expenses
522.70M
449.90M
409.70M
480.30M
Net income
-139.20M
39.80M
5.20M
23.00M
Net profit margin
-9.86%
2.41%
0.31%
1.15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-21.40M
-18.50M
-12.00M
-11.80M
Net interest expenses
-21.40M
-18.50M
-12.00M
-11.80M
Depreciation and amortization charges
83.40M
84.50M
78.80M
79.00M
EBITDA
-177.60M
113.44M
29.55M
60.35M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps